市场调查报告书
商品编码
1345406
全球呼吸迴路市场 - 2023-2030Global Breathing Circuits Market - 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
概述
全球呼吸迴路市场将于 2022 年达到 12 亿美元,预计到 2030 年将达到 17 亿美元,2023-2030 年预测期间复合年增长率为 4.4%。
呼吸迴路的理想特性包括气流阻力低、先前呼出气体的再呼吸最少、以二氧化碳产生的速度去除二氧化碳、需要时输送气体成分的快速变化、吸入气体的加温加湿,并安全处置废气。
呼吸迴路的发展历史与麻醉剂和技术的进步并行。现代呼吸迴路可以根据二氧化碳吸收、阀门位置和稀释新鲜气体的使用等特征进行分类。呼吸迴路的组件包括管道、阀门、储液袋、连接器和输送组件,例如现代体积反射器。
此外,全球呼吸循环是由多种因素驱动的,例如由于有利的监管环境和不断增加的患有慢性疾病的人口,一些主要参与者正在全球范围内扩大其製造设施。呼吸功能障碍发病率的上升也将推动对呼吸迴路的需求。
动力学
呼吸道疾病患病率上升
呼吸道疾病患病率的增加是预测期内帮助市场增长的关键驱动因素之一。由于呼吸系统疾病的增加,根据疾病范围需要通气,确实需要使用呼吸迴路,这确实会增加市场的增长。
例如,根据疾病控制和预防中心的数据,慢性阻塞性肺病估计影响 2000 亿人,每年有 32 亿人死亡,使其成为全球第三大死亡原因。
哮喘是最常见的非传染性疾病之一,影响着全球 2620 亿人。预计到 2022 年,肺癌新增病例将达到近 22 亿,死亡人数将达到 18 亿,肺癌占全球癌症死亡人数的四分之一。下呼吸道感染或肺炎是一个重要的死亡原因,每年造成超过 24 亿人死亡,主要发生在低收入和中等收入国家 (LMIC)。 COVID-19 显着增加了全球肺炎死亡人数。
呼吸迴路的技术进步
呼吸迴路的技术进步是预测期内帮助市场增长的关键因素之一。最近麻醉护理方面取得了一些进展,例如直接注射挥发性麻醉剂、麻醉剂保存装置、红外低成本分析仪和闭路麻醉。
闭路系统已成为麻醉输送系统的最新改进。这些系统通过匹配患者的氧气和麻醉剂消耗来发挥作用,这与之前具有恆定低新鲜气体流量和废气清除系统的方法不同。
阻塞性睡眠呼吸暂停患病率上升
阻塞性睡眠呼吸暂停患病率的上升是预测期内市场加速增长的驱动力。例如,根据美国睡眠呼吸暂停协会的数据,仅 180 亿美国人就患有睡眠呼吸暂停。该统计数据表明,大约每 15 个美国人中就有 1 人(即美国总人口的 6.62%)患有睡眠呼吸暂停。加州大学圣地亚哥分校进行的一项研究对 54 名非裔美国人和 346 名白人进行了睡眠呼吸暂停的研究。
结果显示,17% 的非裔美国人受试者患有阻塞性睡眠呼吸暂停,而白人受试者中这一比例为 8%。这表明非裔美国人患阻塞性睡眠呼吸暂停的风险增加的假设。百分之二到百分之四的美国人患有未确诊的睡眠呼吸暂停病例。这约占每 50 人中就有 1 人未被确诊。
增加 ICU 呼吸迴路的需求
ICU 呼吸迴路需求的增加是预测期内帮助市场增长的关键因素之一。重症监护病房使用呼吸迴路来帮助患者进行呼吸过程。这些电路连接到机械呼吸机,用于向患者提供氧气并去除二氧化碳。呼吸迴路的目的是为患者提供可控且安全的气流,同时通过在呼出的空气或水分到达呼吸机之前收集其来防止感染。因此,呼吸迴路可以将富氧空气输送到患者的肺部,同时去除二氧化碳。
产品召回
产品召回是预测期内阻碍市场增长的因素之一。例如,2023 年 5 月,Draeger Medical 发现由于製造错误,粘合连接可能在通气前或通气过程中鬆动,因此召回了 Seattle PAP Plus 以及 VentStar 和其他呼吸迴路/麻醉套件。结果可能会导致包括聚水器、Y 形接头或软管连接器在内的组件部分或完全脱离。
这些部件鬆动或脱落可能会中断呼吸迴路,并可能导致严重伤害,包括缺氧(缺氧)或死亡。对于包括新生儿(新生儿)在内的重症患者来说,受伤或死亡的风险尤其大。因此,上述因素将限制市场在预测期内的增长。
此外,虽然呼吸迴路在医院、诊所、门诊手术中心和家庭护理机构中的使用不断扩大,但预计有几个问题将限制全球市场的扩张。由于单向阀和二氧化碳吸收增加,患者可能会出现呼吸困难。
Global Breathing Circuits Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 1.7 billion by 2030, growing with a CAGR of 4.4% during the forecast period 2023-2030.
The desirable characteristics of a breathing circuit include low resistance to gas flow, minimal rebreathing of the preceding exhaled gases, removal of carbon dioxide at the rate at which it is produced, rapid changes in delivered gas composition when required, warmed humidification of the inspired gases, and safe disposal of waste gases.
The history of the development of breathing circuits parallels advancements in anaesthetic agents and techniques. Modern breathing circuits can be classified according to characteristics such as carbon dioxide absorption, valve position, and the use of diluting fresh gases. The components of the breathing circuit include the tubing, valves, reservoir bag, connectors, and delivery assemblies such as the modern volume reflector.
Furthermore, the global breathing circuit is driven by various factors, like several key players are expanding their manufacturing facilities across the globe owing to a favourable regulatory environment and an ever, increasing population suffering from chronic ailments. The rising incidence of respiratory dysfunctions is also set to push the demand for breathing circuits.
Increased prevalence of respiratory disease is one the key driver that helps the market to grow during the forecast period. Since rising in respiratory diseases, the need of ventilation is required according to the disease range indeed usage of breathing circuits is needed which indeed will increase the market growth.
For instance, according to the Centres for Disease Control and Prevention COPD affects an estimated 200 Billion people, with 3.2 Billion dying each year, making it the third-leading cause of mortality globally.
Asthma is one of the most common noncommunicable illnesses, impacting 262 Billion people worldwide. With almost 2.2 Billion new instances of lung cancer expected in 2022 and 1.80 Billion fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 Billion fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide.
Technological advancements in breathing circuits are one of the key factors that help the market to grow during the forecast period. Several advancements have happened in anaesthesia care recently, like Direct Injection of Volatile Anesthetics, Anesthetic Agent Conserving devices, Infrared Low-Cost analyzers, and Closed-Circuit Anesthesia.
Closed-circuit systems have become the newest improvement to anaesthesia delivery systems. These systems function by matching both the oxygen and anaesthetic agent consumption of the patient, as opposed to previous methods of having a constant low fresh gas flow and scavenging system for wasted gas.
The rise in the prevalence of obstructive sleep apnea is the driver that helps the market to accelerate during the forecast period. For instance, according to the American Sleep apnea Association Sleep apnea is prevalent in as many as 18 Billion Americans alone. This statistic denotes that approximately 1 in every 15 Americans, or 6.62% of the total American population have a case of sleep apnea. Research conducted at the University of California's San Diego campus studied 54 African Americans and 346 Caucasians for the presence of sleep apnea.
The results showed that a full 17 per cent of African American test subjects had a case of obstructive sleep apnea present, compared to 8 per cent of the Caucasian subjects. This denotes a hypothesis that African Americans stand an increased risk of obstructive sleep apnea. Two to four per cent of all Americans have an undiagnosed case of sleep apnea. This accounts for approximately 1 in 50 individuals being undiagnosed.
Increase demand for breathing circuits in ICUs is one of the key factors that helps the market to grow during the forecast period. Breathing circuits are used in intensive care units to assist patients with their respiratory processes. These circuits are connected to mechanical ventilators, which are used to supply oxygen to the patient and remove carbon dioxide. The breathing circuit's objective is to provide the patient with a regulated and secure gas flow while preventing infection by collecting any exhaled air or moisture before it reaches the ventilator. Hence The breathing circuit allows oxygen-rich air to be delivered to the patient's lungs while also removing carbon dioxide.
Product recall is one of the factors that hamper the market growth during the forecast period. For instance, in May 2023 Draeger Medical recalled the Seattle PAP Plus as well as VentStar and other breathing circuit/anaesthesia kits after finding that glued connections may loosen before or during ventilation due to a manufacturing error. Partial or complete detachment of components including the water trap, y-piece, or hose connector, may occur as a result.
Loosening or detachment of these parts can interrupt the breathing circuit and may cause severe injury including lack of oxygen (hypoxia) or death. The risk of injury or death is especially great for critically ill patients including newborns (neonates). Thus the above factor will restrict the market from growing during the forecast period.
Also, while the use of breathing circuits in hospitals, clinics, ambulatory surgery centres and home care settings continues to expand, several issues are expected to restrain the expansion of the market globally. Patients may experience breathing difficulty due to unidirectional valves and increasing absorption of carbon dioxide.
The global breathing circuits market is segmented based on product type, application, end user and region.
The hospitals segment from the end user segment accounted for 43.1% and it is expected to be dominated during the forecast period. Hospitals are anticipated to increasingly install breathing circuits owing to a rising number of agreements with several distributors, including local and regional firms. Moreover, the presence of advanced tertiary care settings in many countries is set to aid growth. Hospitals nowadays are also striving to provide comprehensive care to patients to push the adoption of breathing circuits globally, which would drive the segment.
For instance, in December 2022, ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze Clear System. This new airway clearance system helps patients clear their airways as well as prevent or treat atelectasis by using Oscillating Lung Expansion (OLE) therapy. BiWaze® Clear can be used to treat both acute and chronic respiratory conditions in the hospital, long-term care and home environments.
North America is estimated to hold about 37.9% of the total market share throughout the forecast period, owing to the significant presence of major market players, flourishing healthcare facilities and increasing hospitalization rates for patients with respiratory diseases.
For instance, in October 2022 Medtronic plc a global leader in healthcare technology stated that company separated its combined patient monitoring and respiratory interventions businesses ("NewCo"), which are part of the company's Medical Surgical Portfolio previously. The Respiratory Interventions technology portfolio includes Puritan Bennett ventilators, Shiley airway portfolio, McGrath MAC video laryngoscopy, DAR breathing systems, as well as PAV+, NIV+ and IE Sync ventilation software solutions designed to improve workflow and care delivery.
Furthermore, in October 2021, ARMSTRONG MEDICAL launched Aqua VENT VT heated ventilator breathing circuits. These breathing circuits are used in critical care settings for mechanical life support ventilation and have been engineered to maintain humidity within the breathing circuits in a simple manner.
The major global players in the market include: Medtronic plc, Ambu A/S, Flexicare Medical Ltd, Fisher & Paykel Healthcare Ltd, Dragerwerk AG & Co, Hamilton Medical, Armstrong Medical Industries Inc, Meditera, GE Healthcare, Bio-Med Devices and among others.
The COVID-19 epidemic has impacted the economies of diverse countries throughout the world in three ways: directly influencing output and demand; disrupting distribution systems; and having a financial impact on corporations and financial markets. Several nations, including Thailand, Indonesia, and Singapore, are experiencing transportation and distribution issues for healthcare items.
During the COVID-19 pandemic, there was an upsurge in demand for ventilators due to their usage in COVID-19 treatment, however, there was a scarcity of ventilators. For instance, on August 26, 2022, the United States Food and Drug Administration (FDA) issued an update about a medical equipment shortage caused by the COVID-19 pandemic. The device shortage list included categories such as dialysis-related items, personal protective equipment, testing supplies and equipment, and ventilation-related products.
Overall, the global breathing circuit market has significant growth in future due to many factors Demand for breathing circuits will remain robust, offsetting any industry margin compression. Several key players are expanding their manufacturing facilities across the globe owing to a favourable regulatory environment and an ever, increasing population suffering from chronic ailments. The rising incidence of respiratory dysfunctions is also set to push the demand for breathing circuits. Hence also in the future upcoming innovations in the ventilation system and a rise in research and development will help the breathing circuit market to accelerate in future with utmost advancements.
The global breathing circuits market report would provide approximately 61 tables, 58 figures and 186 Pages.
LIST NOT EXHAUSTIVE